China: Retail price management case highlights clashing approaches to antitrust law
A ruling by the Shanghai Intermediate People’s Court against Rainbow Medical, which alleged Johnson & Johnson hampered competition with a contract between the two parties, has been appealed to the Shanghai Higher People’s Court. According to a report, the situation is part of a larger trend of conflicting governmental approaches to retail price maintenance cases under the PRC Anti-monopoly Law. Quoted is antitrust lawyer Zhaofeng Zhou, noting that in this particular case the court used an approach “similar to the US rule of reason,” while the National Development and Reform Commission, China’s antitrust authority, used the per se illegal approach “commonly found in the EU.”
Featured News
Live Nation Faces Growing UK Antitrust Pressure Over Industry Influence
Jul 20, 2026 by
CPI
Buchanan Ingersoll Expands Antitrust Practice With Washington Hire
Jul 20, 2026 by
CPI
China Nears Decision in Antitrust Case Against Trip.com
Jul 20, 2026 by
CPI
EU Intensifies Cartel Probe Into Swiss Chemicals Firm Sika
Jul 20, 2026 by
CPI
X and Major Music Publishers Settle Parallel Copyright and Antitrust Cases
Jul 20, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes